Brief Report on the Detection of the EGFR T790M Mutation in Exhaled Breath Condensate from Lung Cancer Patients

Journal of Thoracic Oncology

Volumn 13, Issue 8, 2018, Pages 1213-1216

  Smyth, Robert J ^a   Toomey, Sinead M ^a   Sartori, Alexander ^b   O'Hanrahan, Emer ^c   Cuffe, Sinead D ^d   Breathnach, Oscar S ^e   Morgan, Ross K ^e   Hennessy, Bryan T ^a  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b AGENA BIOSCIENCE   (United States)

^c ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^d ST JAMES S HOSPITAL   (Ireland)

^e BEAUMONT HOSPITAL   (Ireland)

Author keywords

Biomarkers; Exhaled breath condensate; Liquid biopsy; Lung cancer; T790M

Indexed keywords

DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; METHIONINE; THREONINE; CIRCULATING TUMOR DNA; EGFR PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; BREATH ANALYSIS; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; EGFR GENE; EXON; FEMALE; GENE DELETION; GENE INSERTION; GENE MUTATION; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; MALE; MIDDLE AGED; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; VERY ELDERLY; ENZYMOLOGY; EXHALATION; GENETICS; LUNG TUMOR; MUTATION; PATHOLOGY; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; BREATH TESTS; CIRCULATING TUMOR DNA; ERBB RECEPTORS; EXHALATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MUTATION;

EID: 85050207737     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2018.04.033     Document Type: Article

References (15)

1. Lindeman, N.I., Cagle, P.T., Beasley, M.B., et al. Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology. J Thorac Oncol 8 (2013), 823–859.
2. Zhang, Y.-L., Yuan, J.-Q., Wang, K.-F., et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 7 (2016), 78985–78993.
3. Sequist, L.V., Waltman, B.A., Dias-Santagata, D., et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med, 3, 2011, 75ra26.
4. Mok, T.S., Wu, Y.-L., Ahn, M.-J., et al. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med 376 (2017), 629–640.
5. Chouaid, C., Dujon, C., Do, P., et al. Feasibility and clinical impact of re-biopsy in advanced non small-cell lung cancer: a prospective multicenter study in a real-world setting (GFPC study 12-01). Lung Cancer 86 (2014), 170–173.
6. Oxnard, G.R., Paweletz, C.P., Kuang, Y., et al. Noninvasive detection of response and resistance in EGFR-mutant lung cancer using quantitative next-generation genotyping of cell-free plasma DNA. Clin Cancer Res 20 (2014), 1698–1705.
7. Reckamp, K.L., Melnikova, V.O., Karlovich, C., et al. A highly sensitive and quantitative test platform for detection of NSCLC EGFR mutations in urine and plasma. J Thorac Oncol 11 (2016), 1690–1700.
8. Jenkins, S., Yang, J.C., Ramalingam, S.S., et al. Plasma ctDNA analysis for detection of the EGFR T790M mutation in patients with advanced non-small cell lung cancer. J Thorac Oncol 12 (2017), 1061–1070.
9. Haick, H., Broza, Y.Y., Mochalski, P., Ruzasanyi, V., Amann, A., Assessment, origin, and implementation of breath volatile cancer markers. Chem Soc Rev 43 (2014), 1423–1449.
10. Nowak, J., Szemraj, J., Hamara, K., Bialasiewicz, P., Nowak, D., Complete surgical resection of lung tumor decreases exhalation of mutated KRAS oncogene. Respir Med 106 (2012), 1293–1300.
11. Peled, N., Barash, O., Tisch, U., et al. Volatile fingerprints of cancer specific genetic mutations. Nanomedicine 9 (2013), 758–766.
12. Agmon, I.N., Abud, M., Liran, O., et al. Exhaled breath analysis for monitoring response to treatment in advanced lung cancer. J Thorac Oncol 11 (2016), 827–837.
13. Shlomi, D., Abud, M., Liran, O., et al. Detection of lung cancer and EGFR mutation by electronic nose system. J Thorac Oncol 12 (2017), 1544–1551.
14. Mosko, M.J., Nakorchevsky, A.A., Flores, E., et al. Ultrasensitive detection of multiplexed somatic mutations using MALDI-TOF mass spectrometry. J Mol Diagn 18 (2016), 23–31.
15. Cherepanova, A., Tamkovich, S., Pyshnyi, D., et al. Immunochemical assay for deoxyribonuclease activity in body fluids. J Immunol Methods 325 (2007), 96–103.